Kitadate Akihiro

Affiliation and department：

Research field (1)： Hematology and oncology

Research keywords (8)： microRNA , PETCT , CD38 antibody , HDAC inhibitor , Cutaneous T-cell lymphoma , T-cell lymphoma , Multiple myeloma , Malignant lymphoma

Research theme for competitive and other funds (2)：

2020 - 2022 T細胞リンパ腫におけるHDAC阻害剤耐性機構の解明と耐性克服の治療戦略の確立
2017 - 2020 悪性リンパ腫におけるヒストン脱アセチル化酵素が制御するmiRNAの網羅的探索

Papers (56)：

Naoko Enzan, Akihiro Kitadate, Michihiro Kono. Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma. International journal of hematology. 2024
Nagi Tozawa, Takaya Yamashita, Miho Nara, Yuki Fujioka, Sho Ikeda, Takahiro Kobayashi, Isuzu Kobayashi, Akihiro Kitadate, Yoshihiro Kameoka, Naoto Takahashi. Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort Study. Cureus. 2023. 15. 12. e50416
Ko Abe, Sho Ikeda, Miho Nara, Akihiro Kitadate, Hiroyuki Tagawa, Naoto Takahashi. Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myeloma. Cancer medicine. 2023
Honami Sato, Takahiro Kobayashi, Nanako Fujita, Takaya Yamashita, Akihiro Kitadate, Tomoko Yoshioka, Miho Nara, Yoshihiro Kameoka, Masatomo Miura, Naoto Takahashi. Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia. Cancer chemotherapy and pharmacology. 2022. 90. 3. 279-284
Wataru Kuroki, Akihiro Kitadate, Koichi Ishiyama, Yoshihiro Kameoka, Naoto Takahashi. High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma. International journal of hematology. 2022. 116. 5. 712-722

ｍore...

MISC (86)：

黒木航, 北舘明宏. 【多発性骨髄腫と類縁疾患】MGUSの中に潜むMGRSの概念とそのマネージメント. 日本内科学会雑誌. 2023. 112. 7. 1216-1222
黒木航, 北舘明宏. 【新リンパ腫学-基礎・臨床の最新動向-】悪性リンパ腫診療に求められる疾患背景因子の基礎知識自己免疫疾患・慢性炎症と悪性リンパ腫. 日本臨床. 2023. 81. 増刊3 新リンパ腫学. 32-35
北舘明宏. Myeloma kidney from the perspectives of hematologist. 腎と透析. 2022. 92. 2
北舘明宏. 血液疾患をプライマリ・ケアではどこまで診て,どのように専門医と連携をとるべきか?診断・治療方針決定のために専門医へ速やかに紹介することが望ましい場合蛋白上昇,アルブミン低値,免疫グロブリン増加. Medicina. 2021. 58. 13
鈴木花瑠, 円山尚子, 北舘明宏, 田中厚. 【これだけは知っておきたい間葉系腫瘍】寛解時に点滴刺入部位より再発した節外性NK/T細胞リンパ腫. 皮膚病診療. 2020. 42. 5. 438-441

ｍore...

Education (2)：

2013 - 2016 Akita University Graduate School of Medicine
2003 - 2009 Akita University School of Medicine School of Medicine

Professional career (2)：

Ph.D. (Akita University)
M.D. (Akita University)

Work history (10)：

2023/04 - 現在 Akita University Hematology, Nephrology, and Rheumatology Associate professor
2022/04 - 2023/03 Akita University Hospital Clinical Research Promotion and Support Center Associate Professor
2020/09 - 2022/03 Akita University Hospital Clinical Research Promotion and Support Center Assistant Professor
2019/07 - 2020/08 Akita University Department of Hematology, Nephrology, and Rheumatology
2017/07 - 2019/06 Kameda Medical Center Division of Hematology/Oncology, Department of Medicine Head physician

Show all

Awards (7)：

2024/02 - 秋田医学会学術賞
2023/05 - 日本骨髄腫学会奨励賞
2019/12 - American Society of Hematology ASH Abstract Achievment Award
2017/02 - 秋田医学会秋田医学会学術奨励賞
2016/02 - American Association for Cancer Research JCA Scholar-In-Training Award

Show all

Association Membership(s) (6)：

American Society of Hematology , The Japanese Society of Myeloma , THE JAPANESE SOCIETY OF INTERNAL MEDICINE , THE JAPANESE SOCIETY OF HEMATOLOGY , 日本造血・免疫細胞療法学会 , The Japanese Society for Lymphoreticular Tissue Research

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page